Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Paylocity Q3 FY2026 Earnings Call - Recurring Revenue Beats Guide with 11.6% Growth as AI and Managed Services Drive Margin Expansion
Paylocity delivered a strong Q3 FY2026 with recurring and other revenue growing 11.6% year over year to $469.9 million, beating the high end of guidance by $7.4 million. The company raised its full-ye...
- Recurring and other revenue grew 11.6% to $469.9 million, beating the high end of guidance by $7.4 million and driving a full-year guidance raise.
- Total revenue came in $10.3 million above the top end of guidance, marking the third consecutive quarter of guidance beats.
- Adjusted EBITDA margin reached 43.8% ($220.2 million), exceeding guidance by $16.2 million and reflecting 110 basis points of leverage excluding float.
- +7 more takeaways
USA Compression Partners Q1 2026 Earnings Call - Engine Lead Times Triple, J-W Integration Accelerates
USA Compression Partners delivered a disciplined Q1 2026, marked by the successful integration of J-W Power and a strategic pivot to secure long-lead equipment ahead of a tightening market. Management...
- USA Compression Partners contracted over 90% of its 2026 horsepower, totaling nearly 110,000 new units, signaling strong near-term demand visibility.
- J-W Power acquisition closed January 12, adding over 1.037 million horsepower to the fleet and expanding the company’s geographic and operational diversification.
- Engine lead times have tripled from 50 to 150 weeks, prompting USA Compression to secure deposits on engines through 2029 to mitigate supply chain constraints.
- +7 more takeaways
Ultragenyx Q1 2026 Earnings Call - Revenue Growth Accelerates Toward 2027 Profitability Amid Dual Gene Therapy Launches
Ultragenyx delivered a steady Q1 2026 with $136 million in revenue, driven by strong commercial execution across CRYSVITA, DOJOLVI, and EVKEEZA. Management reaffirmed full-year revenue guidance of $73...
- Q1 2026 revenue reached $136 million, with CRYSVITA ($93M), DOJOLVI ($18M), EVKEEZA ($18M), and MEPSEVII ($7M) contributing to steady growth.
- Full-year 2026 revenue guidance reaffirmed at $730–760 million, representing 8–13% growth over 2025, excluding new product revenue.
- Management reaffirmed a clear path to profitability in 2027, with 2026 R&D and SG&A expected to be flat to low single-digit decline versus 2025.
- +9 more takeaways
Super Micro Computer Inc FY2026 Q3 Earnings Call - Gross Margin Rebounds as DCBBS and Enterprise Push Gain Traction
Super Micro Computer reported a sharp gross margin recovery to 10.1% non-GAAP in Q3 FY2026, driven by a better product mix, lower tariff and expedite charges, and an accelerating Data Center Building ...
- Q3 FY2026 revenue of $10.2 billion missed sequentially due to customer site readiness delays and component shortages, but backlog hit record highs.
- Non-GAAP gross margin surged to 10.1%, up from 6.4%, aided by improved product mix, lower tariff/expedite costs, and reduced inventory reserve charges.
- Enterprise channel revenue jumped to 28% of total, up from 15%, signaling a successful pivot beyond large cloud customers.
- +7 more takeaways
InnovAge Q3 2026 Earnings Call - Margin Expansion Outpaces Rate Pressures as AI and Quality Investments Fuel Growth
InnovAge delivered a strong fiscal third quarter, with revenue reaching $252 million and adjusted EBITDA jumping to $30.5 million, driven by better-than-expected Medicaid rates, favorable Medicare ris...
- Revenue reached $251.9 million, up 15.5% year-over-year, driven by higher capitation rates and 6.9% census growth to 8,050 participants.
- Adjusted EBITDA surged to $30.5 million from $10.8 million in the prior year quarter, with margin expanding to 12.1%.
- Full-year 2026 guidance raised: revenue now expected at $950 million-$975 million and adjusted EBITDA at $85 million-$90 million.
- +9 more takeaways
Upwork Q1 2026 Earnings Call - AI Resilience and Cost Discipline Offset Demand Softness
Upwork delivered in-line revenue and a $10 million adjusted EBITDA beat in Q1 2026, but management is adjusting full-year revenue guidance lower due to macro headwinds and accelerated AI adoption at t...
- Upwork reported Q1 2026 revenue in-line with expectations but delivered a $10 million adjusted EBITDA beat, driven by cost discipline and high-margin growth.
- Management lowered full-year 2026 revenue guidance to $760-$790 million due to macro volatility, tariff concerns, and accelerated AI automation at the low end of the marketplace.
- AI-related work is a major bright spot, with annualized GSV exceeding $300 million and growing over 40% year-over-year, representing 8% of total marketplace GSV.
- +7 more takeaways
Carlyle Secured Lending Q1 2026 Earnings Call - Dividend Reset and JV Ramp Signal Earnings Trough
Carlyle Secured Lending reported a steady but pressured first quarter, marked by a dividend reset to $0.35 per share and a strategic pivot toward joint venture scaling. Management emphasized resilient...
- Dividend reset to $0.35 per share for Q2 2026, down from $0.40, reflecting current portfolio earnings power while maintaining supplemental dividend policy.
- New investment spreads widened by 50 basis points in Q1 2026, signaling a shift to a lender-friendly environment with tighter documentation.
- Earnings expected to trough in Q2 2026, with a rebound anticipated in Q3 as joint ventures begin to ramp.
- +7 more takeaways
PRA Group Q1 2026 Earnings Call - Cash Collections Surge 11% as Legal and Digital Channels Drive Operating Leverage
PRA Group delivered a strong Q1 2026 performance, with cash collections rising 11% year-over-year to $552 million and adjusted EBITDA up 14% to $1.3 billion over the last twelve months. The company’s ...
- Cash collections grew 11% year-over-year to $552 million, driven by U.S. legal and digital channels, with cash efficiency improving to 62%.
- Adjusted EBITDA for the last twelve months rose 14% to $1.3 billion, outpacing cash collection growth and signaling expanding operating leverage.
- Net leverage declined to 2.71x from 2.73x in Q4 2025, with a stated target to reach the mid-2x range over the next few years.
- +7 more takeaways
Arcus Biosciences Q1 2026 Earnings Call - Casdatifan Takes Center Stage as PEAK-1 Enrollment Accelerates
Arcus Biosciences is pivoting hard into a new era with full ownership of its lead asset, casdatifan, and a clear, multi-line strategy to dominate the kidney cancer market. The company announced accele...
- Arcus Biosciences has taken full ownership of its lead asset, casdatifan, and is now laser-focused on dominating the kidney cancer market with a multi-line development strategy.
- PEAK-1, the Phase III trial for casdatifan in the second-line setting, is enrolling rapidly with full enrollment targeted by the end of 2026.
- Management claims casdatifan has a superior pharmacodynamic profile and durability compared to competitor belzutifan, citing a 45% confirmed ORR in late-line monotherapy versus belzutifan's historical 22%.
- +9 more takeaways
Emerson Electric Q2 2026 Earnings Call - Software & Systems Driven by Power, AI Positioning Strengthens Amid Middle East Headwinds
Emerson Electric reported Q2 2026 results shaped by a 1-point sales headwind from the Middle East conflict, but underlying momentum remains robust. Software & Systems led with 18% underlying order gro...
- Underlying orders grew 5% in Q2 2026, with Software & Systems up 18%, driven by power, life sciences, and LNG.
- Test & Measurement surged 12%, led by semiconductors and aerospace & defense, with automotive expected to bottom out.
- Middle East conflict caused a 1-point sales headwind (~$50M in Q2), with $100M in rebuild opportunities expected over six quarters.
- +7 more takeaways